Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon
Thumbnail

Emergency hospital transfer of STEMI patients might be expedited with a hospital-level 'Call 911 protocol'

The AHA Mission: Lifeline Program was designed to reduce STEMI patient transfer times, but response times still often lag, and new protocols may be needed to expedite STAT transfers.

Interventional cardiologist Deepak L. Bhatt, MD, named new director of Mount Sinai Heart

Bhatt succeeds Valentin Fuster, MD, PhD, who has held the position since 2006 and will now serve in a more advisory role at Mount Sinai Heart.

Cordis acquires MedAlliance, known for its drug-eluting balloon technology, in deal that could surpass $1B

Cordis to acquire MedAlliance, known for its drug-eluting balloons, in deal that could surpass $1B

The acquisition includes an initial investment of $35 million and an upfront closing payment of $200 million. By 2029, if the companies reach all targeted regulatory and commercial milestones, the acquisition could cost Cordis up to $1.135 billion in all.

cardiologist Peter J. Fitzgerald, MD, PhD, HeartBeam

Cardiac technology startup names cardiologist Peter Fitzgerald its chief medical officer

Fitzgerald, a leading figure in interventional cardiology, praised the company's potential to improve patient outcomes and quality of life. 

Example of QFR technology, which uses a rotation of the C-arm around the patient to create a 3D model and a color coded map showing the FFR values and drops in blood flow.

FFR-angiography guided lesion selection for PCI improves two-year outcomes in TCT late-breaker

Two-year outcomes of a QFR-guided vessel and lesion selection strategy showed that the benefits of QFR guidance continued to accrue over time compared with standard angiography guidance in patients undergoing PCI.

Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock

Regulatory Roundup: FDA clears AI model for RV/LV ratios, approves calcium-blocking TAVR valve and much more

Read our review of some of the biggest FDA-related stories that have hit cardiology in the last month, including news from Viz.ai, Edwards Lifesciences, Abiomed and Medtronic. 

TCT 2022 Robert Califf FDA Commissioner

FDA Commissioner Robert Califf delivers fiery speech on innovation, healthcare disparities and misinformation at TCT 2022

“The United States is essentially inventing the technology and then the rest of the world is figuring out how to use it better,” he said.

The Medtronic CoreValve Evolut and the Edwards Lifesciences Sapien 3 TAVR valves.

TAVR's success has changed how cardiologists and surgeons view aortic valve replacement

The standard-of-care thinking on TAVR has shifted from getting a valve implanted and managing immediate complications to looking decades down the road and considering the patient's long-term health. 

Displaying 57 - 64 of 79

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”